Interaction of apolipoprotein E (apoE) isoforms with amyloid-β (A) peptides is considered a critical determinant of the progression of Alzheimer's disease. However, molecular mechanism of the apoE-A interaction is poorly understood. Here we characterize the nature of the apoE-Aβ complexes and identify the region of apoE that interacts with Aβ. We have prepared three distinct fragments of apoE4, viz., the N-terminal fragment (NTF), hinge domain fragment (HDF) and C-terminal fragment (CTF) to compare its interactions with Aβ. Kinetics of aggregation of Aβ is delayed dramatically in presence of low, substoichiometric concentrations of both NTF and CTF in lipid-free, as well as, in lipidated forms. Effect of HDF is found to be small. Strong inhibition by NTF and CTF at substoichiometric concentrations indicate interactions with the 'intermediates' or the oligomers of Aβ. Kinetics of Forster Resonance Energy Transfer (FRET) between full-length apoE4 labeled with EDANS at positions 62, 139, 210, 247, and 276 and tetramethylrhodamine (TMR)-labeled A further support involvement of multiple regions of apoE in the interactions. Since the interactions involve intermediates of Aβ quantitative evaluation of the binding affinities are not feasible. Hence we employed a competitive binding assay to examine whether the N-and C-terminal domains interact cooperatively. Addition of unlabeled full-length apoE eliminates the FRET between EDANS-NTF + EDANS-CTF and TMR-Aβ almost completely but not vice versa. Furthermore, full-length apoE but not the equimolar mixture of the fragments could displace the already bound EDANS-apoE molecules from the complexes.
Introduction
Pathology of Alzheimer's disease (AD) is characterized by deposition of amyloid β (Aβ) peptides in the form of senile plaques in the brain. However, the strongest genetic risk factor for AD is the ε4 isoform of Apolipoprotein E (apoE) (1) . ApoE is a 299 -residue lipoprotein with three major isoforms, viz., apoE2 (Cys 112, Cys 158), apoE3 (Cys 112, Arg 158) and apoE4 (Arg112, Arg 158). The three isoforms differ by single amino acid substitutions, but their effects on the outcome of AD are immense. How the apoE isoforms influence progression and/or onset of the pathology of AD is still not fully clear. However, numerous studies, both in vitro and in vivo, suggest isoform specific role of apoE proteins on the metabolism of Aβ. For example, apoE4 is found to be associated with impaired uptake, clearance and degradation of Aβ (2) (3) (4) (5) .
Furthermore, presence of the ε4 allele is associated with the higher load of amyloid plaques in the brains of both humans and transgenic mice expressing familial AD mutations (6) (7) (8) . Thus, interactions of the apoE isoforms with Aβ is considered to be one of the most critical determinants of development of AD.
In vitro, apoE isoforms are found to interact with Aβ and alter the kinetics of amyloid aggregation. However, in this regard different groups have reported considerably diverse and sometimes even contradictory observations. For example, a few early studies suggested that apoE isoforms accelerate the aggregation of Aβ in an isoform dependent manner, with apoE4 showing the strongest effects. These studies indicated apoE4 as a pathological chaperone (9, 10) . However, most of the recent studies suggest that apoE isoforms delay the kinetics of the fibrillization of Aβ, possibly by stabilizing the soluble oligomers of Aβ. ApoE4 has the highest and apoE2 has the lowest effects (11) (12) (13) . These authors hypothesized that apoE4 may influence the pathology of AD by increasing the concentration of the soluble oligomers, which are believed to be the major cytotoxic species in AD (11, 14, 15) . The apparently contradictory results are believed to arise due to the transient and heterogeneous nature of both apoE and Aβ.
For example, oligomers of Aβ are known to be highly heterogeneous and transient (16) . In vivo, apoE isoforms exist primarily in the lipidated forms, although it is found in lipidpoor and in lipid-free forms as well (17, 18) .
Furthermore, lipid-free apoE exists as a mixture of monomers, dimers, tetramers and higher order oligomers (19) (20) (21) (22) . While most experiments confirm direct interactions between apoE and Aβ (11, (23) (24) (25) (26) , very little is understood about the biophysical properties of these complexes (reviewed in Tai et al) (27) .
In this article, we attempt to identify the region of apoE involved in the interactions with Aβ. The structure of apoE consists of three distinct domains, viz., an N terminal domain (residues1-167) which contains the receptor binding regions, a C-terminal domain (residues 238-299), which is responsible for oligomerization and binding to lipids, and a flexible hinge region (residues 168-237), which connects the N-and the C-terminal domains (28) . The function of the hinge domain is unknown (22) . The N-terminal domain consists of a four helix bundle, while the C-terminal domain contains a major helical region (residues 238-264) and several stretches of short helices and unstructured regions (28) . Our results suggest that all the three fragments of apoE in isolation interact with Aβ. However, the intact form of apoE interacts with the highest affinity.
Materials and Methods
All the chemicals unless otherwise stated are purchased from Sigma Aldrich (Sigma, St.
Louis, MO).
Purification of Aβ42
Chemically synthesized Aβ42, TMR-labeled Aβ42 (TMR-Aβ42) and EDANS-labeled Aβ42
(EDANS-Aβ42) are purchased from AAPPTec LLC (Louisville, KY, USA). TMR is attached to the N-terminal amine as described previously (34) . EDANS is attached to the N-terminal of Aβ using fmoc-Glu(EDANS)-OH. Aggregation properties of TMR-Aβ has been reported earlier (34, 35) . Stock solutions of Aβ42, TMR-Aβ42, and EDANS-Aβ42 have been prepared by using the protocol described by Sil et al (34) .
Briefly, lyophilized powder of the peptide is 
Expression and Purification of the fulllength and the fragments of apoE4
The WT-apoE4 plasmid is a kind gift from Dr.
Carl Frieden (Washington University, St. The lipidation of apoE is confirmed using fluorescence spectrum of the tryptophan residues in apoE with a characteristic blue shift of the peak (see Figure S1 ). We have noticed that lipid-free apoE is prone to oxidation and oligomerization (data not shown). Hence we add 5 mM βMe to all the solutions of apoE. Figure S2A ). Figure 1A shows NTF, the total fluorescence of ThT is also reduced significantly. Therefore, NTF delays and reduces the fibrillization of Aβ42 in a dose dependent manner. Figure 1B shows that similar effects are also observed in presence of the CTF. Figure 1C shows that HDF also has delaying effects on the aggregation kinetics of A but the effects are significantly less than the NTF and the CTF. Figure 1D Aβ with high affinities is not clear. We speculate that this could happen due to dynamic equilibrium between the lipidated and the lipidfree forms of apoE (38) . We note here that we haven't used DMPC-HDF because this HDF couldn't be lipidated (data not shown).
Fluorescence labeling of the single cysteine mutants of apoE4 and the fragments

Comparison between the full-length intact
apoE4 and the fragments mixed together. The Fluorescence correlation spectroscopy data presented here in Figure S5 indicate that apoE doesn't interact with Aβ appreciably even at micromolar concentrations. Therefore, we hypothesize that apoE interacts weakly with the monomers of Aβ but strongly with the 'intermediates' or the oligomers of Aβ (11) (12) (13) 36 ).
To investigate the interaction between apoE and the oligomers of Aβ here we have followed the time evolution of the intermolecular FRET. In these experiments, we have used EDANS-Aβ42 and unlabeled apoE4.
Fibrillization of EDANS-Aβ42 has been verified using imaging of the aggregates by AFM (see Figure S6 ). Here the native tryptophan residues in apoE are the FRET donor and EDANS is the acceptor. We note here that the NTF, HDF and CTF contain four, one and two tryptophan residues respectively. In these experiments, EDANS is attached to a single cysteine residue that has been introduced by site-directed mutagenesis in different locations in the sequence of apoE4. Here we have used 5 different single cysteine mutants of full-length apoE4, viz., A62C, S139C, W210C, A247C, and W276C for labeling with EDANS.
These mutants are chosen to cover all the three domains, viz., the N-and C-terminal, and the hinge-domain. Figure 4B shows that the kinetics of FRET between apoE and Aβ are similar for all the five mutants. The extent of the FRET is the highest for the A62C region followed by A247C, W276C, W210C and S139C regions. Similar time-dependent increase of the FRET is also observed with EDANS-labeled lipidated apoE (see Figure   S7 ). Therefore, apoE-Aβ interactions can be characterized as multivalent binding involving multiple binding sites on apoE and the oligomers of Aβ (39) . Figure S8 ). Therefore, the fragments of apoE compete poorly with the full-length protein to interact with Aβ. Figure 5B amount of CTF appears to enhance the FRET between the EDANS-NTF and TMR-Aβ (see Figure 5C ). The reason for the enhanced FRET is not clear but this may indicate cooperativity between NTF and CTF to interact with TMR-Aβ.
Reversal of FRET between EDANS-apoE and
TMR-Aβ by unlabeled apoE. We examine the competition between the fragments and the fulllength apoE with TMR-Aβ further by using an alternative approach. In this approach first, we monitor the kinetics of FRET between EDANS-apoE and TMR-Aβ for several hours, then we Furthermore, Figure 6B shows that the FRET between TMR-Aβ and the EDANS-NTF + EDANS-CTF can be reversed almost completely by addition of unlabeled apoE.
Taken together the data presented in Figure 6 indicate that the affinity of full-length apoE4 for binding to TMR-Aβ is much higher than the resultant affinity of the fragments mixed together. It may be noted here that the reversal of FRET, i.e., the dissociation of EDANS-apoE from its complex with TMR-Aβ in presence of unlabeled apoE is a slow process taking several hours. It is possible that the apoE molecules undergo structural reorganization upon binding to Aβ oligomers forming highly stable complexes, which dissociate very slowly.
Discussions
Numerous in vivo and in vitro studies indicate isoform specific role of the apoE on metabolism of the Aβ peptides in the brain (27, (41) (42) (43) .
ApoE-Aβ complexes have been detected both in soluble forms and insoluble plaques in the transgenic AD mice and in the human brains (7) (8) (9) . Thus, understanding apoE-Aβ interaction is believed to be critically important to decipher the isoform specific roles of apoE in AD.
However The primary goal of the present work is to identify the regions of apoE that interact with A. Since the interaction of apoE occurs with non-equilibrium species of A, we have pursued a kinetic approach to follow the interactions between these proteins. First, we have shown that all the three fragments, viz., the NTF, CTF, and HDF can delay the aggregation of A even at substoichiometric concentrations, although the effects of HDF is relatively small (see Figure 1C ). Then, using FRET we find that all the three domains in isolation as well as in the intact apoE interact with A ( Figure 4 ). interactions, i.e., ∆Gtot << ∑∆Gi (40) . We note here that the schematic presented in Figure 7 is qualitative in nature, as the exact number of binding sites on apoE, the size of the oligomers of Aβ and ∆G of the interactions are unknown.
Furthermore, in this study we haven't examined interactions of apoE with the Aβ fibrils.
However, such interactions have been reported earlier (12) . We also note here that the combined effect of the fragments on the kinetics of aggregation of Aβ is found to be comparable to the full-length apoE (see Biological significance. Interactions between apoE and Aβ are believed to play critical roles in metabolism of Aβ in the brain (27, (41) (42) (43) . In this work, we haven't explored the physiological activities of the apoE-Aβ complexes. While the data presented here indicate that apoE inhibits aggregation of A, physiological implications of these interactions could be several folds. For example, apoE-A interactions can promote clearance, uptake, and degradation of the toxic oligomers of A via the apoE receptors (27, 41) . Alternatively, apoE-A interactions can have harmful effects due to stabilization of the cytotoxic oligomers of A (11, 12, 14, 36) . Furthermore, physiological functions of apoE may be compromised due to its interactions with the A oligomers (23) . A major outcome of the study presented here is that high affinity interactions with the Aβ oligomers requires full-length apoE. However, proteolytic fragmentation of apoE, particularly of apoE4, have been detected in the brain around the plaques and inside the neuronal cells (29, 50, 51) . Therefore, the proteolytic susceptibility of apoE4 may hinder its interaction with Aβ in vivo leading to inefficient clearance of the oligomers of Aβ in the brain (52) . This is consistent with the reports that apoE4 is associated with impaired clearance of Aβ from ISF (4, 42) .
In 
